Phase 3b, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Chronic Constipation and Prominent Abdominal Bloating at Baseline.

Trial Profile

Phase 3b, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Chronic Constipation and Prominent Abdominal Bloating at Baseline.

Completed
Phase of Trial: Phase III

Latest Information Update: 28 Apr 2016

At a glance

  • Drugs Linaclotide (Primary)
  • Indications Constipation
  • Focus Therapeutic Use
  • Sponsors Forest Laboratories
  • Most Recent Events

    • 19 Oct 2015 Results presented at the American College of Gastroenterology 2015 Scientific Meeting, as per Ironwood Pharmaceuticals media release.
    • 01 Aug 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 25 Jul 2013 Data is expected from this trial in Q3 2013, according to an Ironwood media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top